Comparative Pharmacology
Head-to-head clinical analysis: ISOLYTE R IN DEXTROSE 5 IN PLASTIC CONTAINER versus ISOLYTE R W DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ISOLYTE R IN DEXTROSE 5 IN PLASTIC CONTAINER versus ISOLYTE R W DEXTROSE 5 IN PLASTIC CONTAINER.
ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER vs ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Electrolyte and fluid replacement; dextrose provides caloric support.
Isolyte R with Dextrose 5% is an intravenous solution providing electrolytes (sodium, potassium, magnesium, calcium, chloride, acetate, gluconate) and dextrose. Dextrose provides calories and may prevent ketosis; electrolytes maintain or restore acid-base balance and provide essential ions for cellular function.
Intravenous infusion; rate based on fluid and electrolyte requirements, typically 1-2 mL/kg/hour for maintenance in adults.
Intravenous infusion at a rate of 125-200 mL/hour (3 mL/kg/hour) for fluid and electrolyte maintenance, adjusted based on clinical status, serum electrolytes, and glucose monitoring.
None Documented
None Documented
Not applicable; components are endogenous substances. Dextrose has a plasma half-life of approximately 1.5-2.5 hours in normal glucose metabolism; electrolytes have half-lives dependent on renal function (e.g., sodium half-life ~1-2 days).
Not applicable as a composite solution; glucose half-life ~1.5-2 h in normal individuals, extended in renal impairment; electrolytes follow body homeostasis.
Renal excretion of water and electrolytes; dextrose is metabolized to CO2 and water. >90% of water and electrolytes are excreted renally; dextrose is fully metabolized.
Renal: ~100% as water, electrolytes, and glucose; no biliary or fecal elimination of active drug components.
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution